Best TWAS P=2.82e-11 · Best GWAS P=3.44e-08 conditioned to 0.536
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ARFRP1 | 0.07 | 0.07 | lasso | 3 | 0.06 | 5.3e-08 | -5.4 | 5.6 | 1.6e-08 | -0.89 | 0.02 | 0.98 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | STMN3 | 0.07 | 0.02 | lasso | 4 | 0.05 | 2.8e-06 | -5.5 | -5.3 | 1.1e-07 | 0.76 | 0.02 | 0.98 | FALSE |
3 | GTEx | Brain Cerebellar Hemisphere | STMN3 | 0.39 | 0.08 | lasso | 5 | 0.22 | 2.1e-06 | -4.8 | -5.4 | 5.1e-08 | 0.62 | 0.04 | 0.90 | FALSE |
4 | GTEx | Brain Cerebellum | STMN3 | 0.33 | 0.12 | lasso | 10 | 0.20 | 1.8e-06 | -5.2 | -5.2 | 2.3e-07 | 0.78 | 0.02 | 0.97 | FALSE |
5 | GTEx | Brain Cortex | STMN3 | 0.25 | 0.09 | lasso | 7 | 0.11 | 6.8e-04 | -5.4 | -5.2 | 1.7e-07 | 0.92 | 0.02 | 0.93 | FALSE |
6 | GTEx | Testis | RTEL1 | 0.19 | 0.06 | lasso | 5 | 0.14 | 8.0e-07 | -5.4 | -6.7 | 2.8e-11 | 0.77 | 0.02 | 0.95 | TRUE |
7 | YFS | Blood | LIME1 | 0.12 | 0.19 | enet | 15 | 0.19 | 5.3e-59 | -5.2 | -5.3 | 1.1e-07 | 0.73 | 0.03 | 0.97 | FALSE |
8 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LIME1 | 0.02 | 0.03 | blup | 47 | 0.02 | 6.2e-03 | -5.4 | -5.2 | 1.9e-07 | 0.93 | 0.01 | 0.86 | FALSE |
9 | The Cancer Genome Atlas | Lung Adenocarcinoma | TNFRSF6B | 0.02 | 0.01 | enet | 7 | 0.01 | 6.9e-03 | -5.2 | -5.6 | 1.6e-08 | 0.93 | 0.02 | 0.88 | FALSE |
10 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | RTEL1 | 0.05 | 0.04 | blup | 56 | 0.03 | 4.2e-03 | -3.3 | -6.0 | 2.5e-09 | 0.78 | 0.02 | 0.67 | FALSE |
11 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ARFRP1 | 0.03 | 0.02 | lasso | 2 | 0.02 | 1.2e-03 | -5.4 | 5.4 | 7.5e-08 | -0.78 | 0.02 | 0.92 | FALSE |
12 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ZGPAT | 0.05 | 0.06 | lasso | 3 | 0.06 | 5.5e-07 | -5.5 | 5.7 | 1.4e-08 | -0.99 | 0.01 | 0.99 | FALSE |